Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 463Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Cohance Lifesciences

02 1Octavius Pharma Pvt. Ltd

03 2Altius Healthcare

04 2Apotex Inc

05 2Ascent Innovative Medicines

06 1Aspire Lifesciences Pvt Ltd

07 2ENDO OPERATIONS

08 2Kolmar Korea Co., Ltd.

09 2Laboratorio Eczane Pharma

10 1Loxim Industries

11 4Murli Krishna Pharma

12 2Orchid Pharma

13 4Pelcoat Formulations

14 2Smilax Laboratories Limited

15 2TWi Pharmaceuticals

16 11Takeda Pharmaceutical

17 2Viatris

18 4World Medicine

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Immuno-Oncology 360
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Regulatory Info :

Registration Country : India

Dexlansoprazole

Brand Name :

Dosage Form : Capsule

Dosage Strength : 30MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Cohance

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothOctavius has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.

Regulatory Info :

Registration Country : India

Dexlansoprazole

Brand Name : Dexlansoprazole

Dosage Form : Pellets/Micro pellets for capsules

Dosage Strength : 17; 20; 22.5; 23%; %; %; %

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Octavius Pharma

03

arrow
Immuno-Oncology 360
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Regulatory Info :

Registration Country : India

Dexlansoprazole

Brand Name :

Dosage Form : Capsule

Dosage Strength : 60MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Cohance

04

arrow
Immuno-Oncology 360
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Regulatory Info :

Registration Country : India

Dexlansoprazole

Brand Name :

Dosage Form : Delayed Release Pellet

Dosage Strength : 22.5%

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Cohance

05

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

Dexlansoprazole

Brand Name :

Dosage Form : DR Capsule

Dosage Strength : 30MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

06

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

Dexlansoprazole

Brand Name :

Dosage Form : DR Capsule

Dosage Strength : 60MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

07

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

Dexlansoprazole

Brand Name :

Dosage Form : Pellets

Dosage Strength : 17%W/W

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

08

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

Dexlansoprazole

Brand Name : Decpranzole Tablet

Dosage Form : Tablet

Dosage Strength : 30MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : South Korea

blank

09

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

Dexlansoprazole

Brand Name : Decpranzole Tablet

Dosage Form : Tablet

Dosage Strength : 60MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : South Korea

blank

10

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

Dexlansoprazole

Brand Name : Dexprane

Dosage Form : Capsule

Dosage Strength : 30MG

Packaging : 30 Caps

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Argentina

blank

11

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

Dexlansoprazole

Brand Name : Dexprane

Dosage Form : Capsule

Dosage Strength : 60MG

Packaging : 30 Caps

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Argentina

blank

12

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

Dexlansoprazole

Brand Name :

Dosage Form : DR CAPSULE

Dosage Strength : 30MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic EU CTD

Registration Country : India

blank

13

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

Dexlansoprazole

Brand Name :

Dosage Form : DR CAPSULE

Dosage Strength : 60MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic EU CTD

Registration Country : India

blank

14

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

Dexlansoprazole

Brand Name :

Dosage Form : Enteric Coated Pellets

Dosage Strength : 8.5%/W/W

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

15

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

Dexlansoprazole

Brand Name :

Dosage Form : Enteric Coated Pellets

Dosage Strength : 15%/W/W

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

16

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

Dexlansoprazole

Brand Name :

Dosage Form : Enteric Coated Pellets

Dosage Strength : 17%/W/W

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

17

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

Dexlansoprazole

Brand Name :

Dosage Form : Enteric Coated Pellets

Dosage Strength : 20%/W/W

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

18

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

DEXLANSOPRAZOLE

Brand Name : DEXILANT

Dosage Form : CAPSULE, DELAYED RELEASE;ORAL

Dosage Strength : 30MG

Packaging :

Approval Date : 2009-01-30

Application Number : 22287

Regulatory Info : RX

Registration Country : USA

blank

19

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

DEXLANSOPRAZOLE

Brand Name : DEXILANT

Dosage Form : CAPSULE, DELAYED RELEASE;ORAL

Dosage Strength : 60MG

Packaging :

Approval Date : 2009-01-30

Application Number : 22287

Regulatory Info : RX

Registration Country : USA

blank

20

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

DEXLANSOPRAZOLE

Brand Name : DEXILANT SOLUTAB

Dosage Form : TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL

Dosage Strength : 30MG

Packaging :

Approval Date : 2016-01-26

Application Number : 208056

Regulatory Info : DISCN

Registration Country : USA

blank

21

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

DEXLANSOPRAZOLE

Brand Name : DEXLANSOPRAZOLE

Dosage Form : CAPSULE, DELAYED RELEASE;ORAL

Dosage Strength : 30MG

Packaging :

Approval Date : 2022-09-16

Application Number : 202666

Regulatory Info : RX

Registration Country : USA

blank

22

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

DEXLANSOPRAZOLE

Brand Name : DEXLANSOPRAZOLE

Dosage Form : CAPSULE, DELAYED RELEASE;ORAL

Dosage Strength : 60MG

Packaging :

Approval Date : 2022-09-16

Application Number : 202666

Regulatory Info : RX

Registration Country : USA

blank

23

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

DEXLANSOPRAZOLE

Brand Name : DEXLANSOPRAZOLE

Dosage Form : CAPSULE, DELAYED RELEASE;ORAL

Dosage Strength : 30MG

Packaging :

Approval Date : 2024-01-19

Application Number : 205205

Regulatory Info : RX

Registration Country : USA

blank

24

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

DEXLANSOPRAZOLE

Brand Name : DEXLANSOPRAZOLE

Dosage Form : CAPSULE, DELAYED RELEASE;ORAL

Dosage Strength : 60MG

Packaging :

Approval Date : 2024-01-19

Application Number : 205205

Regulatory Info : RX

Registration Country : USA

blank

25

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

Dexlansoprazole

Brand Name :

Dosage Form : CAPSULE

Dosage Strength : 30MG

Packaging : 14 Or 28 Capsules

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : Turkey

blank

26

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

Dexlansoprazole

Brand Name :

Dosage Form : CAPSULE

Dosage Strength : 60MG

Packaging : 14 Or 28 Capsules

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : Turkey

blank

27

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

Dexlansoprazole

Brand Name : EKSDELAN

Dosage Form : CAPSULE

Dosage Strength : 30MG

Packaging : 14 OR 28 CAPSULES

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Turkey

blank

28

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

Dexlansoprazole

Brand Name : EKSDELAN

Dosage Form : CAPSULE

Dosage Strength : 60MG

Packaging : 14 OR 28 CAPSULES

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Turkey

blank

29

ENDO OPERATIONS

Country
Immuno-Oncology 360
Not Confirmed
arrow

ENDO OPERATIONS

Country
arrow
Immuno-Oncology 360
Not Confirmed

DEXLANSOPRAZOLE

Brand Name : DEXLANSOPRAZOLE

Dosage Form : CAPSULE, DELAYED RELEASE;ORAL

Dosage Strength : 60MG

Packaging :

Approval Date : 2017-04-19

Application Number : 202294

Regulatory Info : RX

Registration Country : USA

blank

30

ENDO OPERATIONS

Country
Immuno-Oncology 360
Not Confirmed
arrow

ENDO OPERATIONS

Country
arrow
Immuno-Oncology 360
Not Confirmed

DEXLANSOPRAZOLE

Brand Name : DEXLANSOPRAZOLE

Dosage Form : CAPSULE, DELAYED RELEASE;ORAL

Dosage Strength : 30MG

Packaging :

Approval Date : 2022-06-16

Application Number : 202294

Regulatory Info : RX

Registration Country : USA

blank